Roland Grenningloh

Ets-1 is a negative regulator of Th17 differentiation

Jacques Moisan, Roland Grenningloh, Estelle Bettelli et al. · The Journal of Experimental Medicine · 2007 · 202 citations · Full text

Life Sciences, Immunology, Pathology +13

Ability of Bruton’s Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling

Andrew T. Bender, A.S. Gardberg, Albertina Pereira et al. · Molecular Pharmacology · 2017 · 188 citations

Life Sciences, Immunology, Pharmacology +17

Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models

Philipp Haselmayer, Montserrat Camps, Lesley Liu‐Bujalski et al. · The Journal of Immunology · 2019 · 148 citations · Full text

Medicine, Immunology, Pharmacology +17

Cysteinyl Leukotrienes Regulate Th2 Cell-Dependent Pulmonary Inflammation

Daniel C. Kim, Florence Ida Hsu, Nora A. Barrett et al. · The Journal of Immunology · 2006 · 141 citations

Life Sciences, Immunology, Pharmacology +16

Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases

Richard D. Caldwell, Hui Qiu, Ben Askew et al. · Journal of Medicinal Chemistry · 2019 · 140 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14